Pure Global

Insulin syringe, retractable-needle - ARTG 413350

Access comprehensive regulatory information for Insulin syringe, retractable-needle in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 413350 and sponsored by LC & Partners Pty Ltd, manufactured by Shanghai Kindly Enterprise Development Group Co Ltd in China. The device registration started on July 12, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
ARTG 413350
Class IIa
Insulin syringe, retractable-needle
ARTG ID: 413350
Good Name: LC & Partners Pty Ltd - Insulin syringe, retractable-needle
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

The product intended for subcutaneous injection of U 40 or U 100 insulin into the body , the sliding sleeve helps protect against needle puncture once activated.

Device Classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration Information
ARTG ID
413350
Start Date
July 12, 2023
Effective Date
July 12, 2023
Manufacturer
Country
China
Address
No 658 Gaochao Road, Shanghai, 201803